In vitro circadian ANP secretion by gene transferring cells encapsulated in polycaprolactone tubes: Gene chronotherapy

Zhengrong Wang, Liguo Chen, Chaomin Wan, Yi Qu, Germaine G Cornelissen-Guillaume, F. Halberg

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

A new insofar as chronobiologic therapeutic approach by atrial natriuretic peptide (ANP) for hypertension and/or congestive heart failure (CHF) is based on the release of ANP from ANP cDNA transfected Chinese Hamster Ovary (CHO) cells encapsulated in polycaprolactone (PCL) tubes. ANP secretion was maintained for at least 6 months. The encapsulated cells remained viable during culturing. Control cells without transferred ANP cDNA were negative. ANP secretion is circadian periodic, peaking around 04:18, shifted to around 07:56 by melatonin treatment. The encapsulation technique, based on principles of chronotherapy, may provide a more efficient gene therapy, applicable for eventual human implantation of gene transferred cells.

Original languageEnglish (US)
Pages (from-to)1259-1267
Number of pages9
JournalPeptides
Volume25
Issue number8
DOIs
StatePublished - Aug 2004

Bibliographical note

Funding Information:
National Nature Science Foundation of China (project 39970275, 30070278 for W.Z. and 30070198 for W.C.); U.S. Public Health Service (GM-13981) (F.H.); Dr. h.c. Dr. h.c. Earl Bakken Fund (G.C., F.H.); University of Minnesota Supercomputing Institute (G.C., F.H.).

Keywords

  • ANP
  • CHF
  • CHO
  • CHO cells
  • Chinese hamster ovary
  • Chronobiology
  • Circadian rhythm
  • Congestive heart failure
  • Encapsulation
  • PCL
  • RIA
  • atrial natriuretic peptide
  • congestive heart failure
  • hANP
  • human atrial natriuretic peptide
  • polycaprolactone
  • radioimmunoassay

Fingerprint

Dive into the research topics of 'In vitro circadian ANP secretion by gene transferring cells encapsulated in polycaprolactone tubes: Gene chronotherapy'. Together they form a unique fingerprint.

Cite this